Stockscreener 앱 받기
8.85
0.45%
-0.04
시간 외 거래:
8.84
-0.010
-0.11%
Enanta Pharmaceuticals Inc 주식(ENTA)의 최신 뉴스
Short interest data insights for Enanta Pharmaceuticals Inc.July 2025 Weekly Recap & Fast Exit and Entry Strategy Plans - Newser
Key resistance and support levels for Enanta Pharmaceuticals Inc.Share Buyback & Daily Volume Surge Trade Alerts - Newser
Real time pattern detection on Enanta Pharmaceuticals Inc. stockTrade Signal Summary & High Win Rate Trade Tips - Newser
How to interpret RSI for Enanta Pharmaceuticals Inc. stockAnalyst Upgrade & Accurate Intraday Trade Tips - Newser
Tools to monitor Enanta Pharmaceuticals Inc. recovery probabilityPortfolio Return Report & High Accuracy Swing Entry Alerts - Newser
How high can Enanta Pharmaceuticals Inc. stock go2025 Trading Volume Trends & Safe Entry Zone Tips - Newser
What recovery options are there for Enanta Pharmaceuticals Inc.2025 Buyback Activity & Daily Profit Focused Screening - Newser
Sentiment analysis tools applied to Enanta Pharmaceuticals Inc.July 2025 Analyst Calls & Daily Technical Stock Forecast Reports - Newser
What’s the outlook for Enanta Pharmaceuticals Inc.’s sectorMarket Growth Report & Consistent Profit Trading Strategies - خودرو بانک
Visualizing Enanta Pharmaceuticals Inc. stock with heatmapsWeekly Profit Report & Detailed Earnings Play Strategies - Newser
Using data filters to optimize entry into Enanta Pharmaceuticals Inc.Trade Exit Report & Fast Exit Strategy with Risk Control - Newser
What are the future prospects of Enanta Pharmaceuticals Inc.Weekly Trading Summary & Technical Buy Zone Confirmation - خودرو بانک
How to manage a losing position in Enanta Pharmaceuticals Inc.Trade Exit Report & Comprehensive Market Scan Insights - Newser
How to build a dashboard for Enanta Pharmaceuticals Inc. stockBull Run & Entry Point Confirmation Alerts - Newser
Applying Elliott Wave Theory to Enanta Pharmaceuticals Inc.Bull Run & Daily Risk Controlled Trade Plans - Newser
Is a relief rally coming for Enanta Pharmaceuticals Inc. holdersTrade Analysis Summary & Stepwise Trade Signal Guides - Newser
What MACD and RSI say about Enanta Pharmaceuticals Inc.Gold Moves & Real-Time Price Movement Reports - Newser
Will Enanta Pharmaceuticals Inc. see short term momentumWeekly Risk Summary & Capital Efficient Trading Techniques - Newser
Using data tools to time your Enanta Pharmaceuticals Inc. exit2025 Support & Resistance & Free Fast Gain Swing Trade Alerts - Newser
How to build a custom watchlist for Enanta Pharmaceuticals Inc.Index Update & AI Enhanced Trading Alerts - Newser
Real time social sentiment graph for Enanta Pharmaceuticals Inc.Weekly Trading Summary & Safe Entry Momentum Stock Tips - Newser
Enanta CFO dies after taking medical leave of absence - CFO Dive
Enanta Pharmaceuticals Announces the Passing of Chief Financial and Administrative Officer Paul J. Mellett Jr. - citybiz
Enanta Pharmaceuticals Appoints Interim Financial Officers - MSN
Enanta Pharmaceuticals Announces the Passing of its Beloved and - GuruFocus
Enanta Pharmaceuticals Announces the Passing of its Beloved and Respected Longtime Chief Financial a - PharmiWeb.com
Live market analysis of Enanta Pharmaceuticals Inc.Portfolio Profit Report & Weekly Stock Performance Updates - Newser
Enanta Pharmaceuticals announces passing of longtime CFO Paul Mellett - Investing.com
Enanta Pharmaceuticals, Inc.'s (NASDAQ:ENTA) Price Is Right But Growth Is Lacking After Shares Rocket 27% - simplywall.st
Enanta Pharmaceuticals: Leadership Continuity and Strategic Resilience in Biotech R&D - AInvest
Enanta Pharmaceuticals Chief Financial, Administrative Officer Dies - MarketScreener
Enanta Pharmaceuticals Receives New 'Buy' Rating from WestPark Capital with $24.00 Price Target - AInvest
Enanta Pharmaceuticals Announces Passing of Chief Financial and Administrative Officer Paul J. Mellett Jr. - AInvest
Enanta Pharmaceuticals Announces the Passing of its Beloved and Respected Longtime Chief Financial and Administrative Officer Paul J. Mellett Jr. - Business Wire
Historical volatility pattern of Enanta Pharmaceuticals Inc. visualizedJuly 2025 Sector Moves & Reliable Entry Point Alerts - Newser
Measuring Enanta Pharmaceuticals Inc.’s beta against major indicesJuly 2025 Momentum & Accurate Entry and Exit Point Alerts - Newser
Published on: 2025-09-03 03:49:04 - Newser
Can you recover from losses in Enanta Pharmaceuticals Inc.2025 Investor Takeaways & Expert Approved Trade Ideas - Newser
Is Enanta Pharmaceuticals Inc. reversing from oversold territory2025 Technical Patterns & AI Driven Price Predictions - Newser
Is Enanta Pharmaceuticals Inc. forming a breakout patternJuly 2025 Movers & Technical Buy Zone Confirmations - خودرو بانک
Enanta Pharma (ENTA) Receives New 'Buy' Rating from WestPark Cap - GuruFocus
Can momentum traders help lift Enanta Pharmaceuticals Inc.2025 Sector Review & Consistent Profit Trading Strategies - Newser
Enanta Pharmaceuticals: WestPark Capital initiates coverage with a Buy rating and $24 PT. - AInvest
1.40%
자본화:
|
볼륨(24시간):